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Abstract 
A decrease in the drug release rate over time typically affects the performance of hydrophilic matrices for 
oral prolonged release. To address such an issue, a Non-Uniform Drug Distribution Matrix (NUDDMat) 
based on hypromellose was proposed and demonstrated to yield zero-order release. The system consisted of 30 
5 overlaid layers, applied by powder layering, having drug concentration decreasing from the inside towards 
the outside of the matrix according to a descending staircase function. In the present study, manufacturing 
and performance of the described delivery platform were evaluated using drug tracers having different water 
solubility. Lansoprazole, acetaminophen and losartan potassium were selected as slightly (SST), moderately 
(MST) and highly (HST) soluble tracers. By halving the thickness of the external layer, which contained no 35 
drug, linear release of HST and MST was obtained. The release behavior of the NUDDMat system loaded 
with a drug having pH-independent solubility was shown to be consistent in pH 1.2, 4.5 and 6.8 media. 
Based on these results, feasibility of the NUDDMat platform by powder layering was demonstrated using 
drugs having different physico-technological characteristics. Moreover, its ability to generate zero-order 
release was proved in the case of drugs with water solubility in a relatively wide range. 40 
 
1. Introduction 
Zero-order release kinetics has long been studied and documented in the literature for reaching constant drug 
absorption rate and thereby allowing to obtain constant drug plasma levels between two successive doses. 
Several attempts have been reported presenting different strategies, which involve mechanical restriction of 45 
swelling, application of partial coatings and/or design of modified geometries (Colombo et al., 1990, 1987; 
Gazzaniga et al., 1993; Grassi et al., 2004; Kim, 1995; Sangalli et al., 1994, 1993, 2003; Siepmann and 
Peppas, 2001; Zema et al., 2010). Such delivery systems are designed to limit the gradual increase of the 
diffusion path or to progressively broad the surface at the solvent penetration front within the matrix. 
Another approach is based on increasing drug concentration from the outside towards the inside of the 50 
dosage unit, in order to compensate for the longer diffusion path and the smaller surface available for 
diffusion. These are the so-called gradient matrix systems (de Haan and Lerk, 1986b, 1986a; Dekyndt et al., 
2015; Hildgen and McMullen, 1995; Huang et al., 2002; James Chang and Himmelstein, 1990; Lee, 1986, 
1984; Mazzoni et al., 2019; Scott and Hollenbeck, 1991; van Bommel et al., 1991). In particular, inert or 
hydrophilic matrix systems having non-uniform drug distribution have been proposed, depending on the type 55 
of polymer used for controlling release. Tableted systems have been prepared as multilayer or concentric 
units having gradient concentration of the active ingredient (Conte and Maggi, 1996; Fassihi and Ritschel, 
1993; MacLeod et al., 1999; Phaechamud, 2008; Zoglio and Carstensen, 1984). Matrices with different drug 
concentration inside have been attained by soaking (Forni et al., 1989). In different instances, controlled drug 
sedimentation was exploited via centrifugation of drug particles in a molten polymer (Hildgen and 60 
McMullen, 1995). Coated systems having non-uniform drug concentration have been prepared by spraying 
onto inert cores dispersions of the polymer and the drug with different concentration ratios, thus creating 
sequential layers with non-homogeneous drug distribution (Bogentoft and Appelgren, 1984; Dekyndt et al., 
2015; Li and Tu, 1991; van Bommel et al., 1989; Van Bommel et al., 1990; Wan and Lai, 1992). Monolithic 
systems were 3D printed including complex structures having increasing concentrations of the release 65 
modulating materials from the periphery to the center (Deng et al., 2007; Monkhouse et al., 2001). All these 
approaches successfully led to in vitro zero-order drug release profiles. 
Recently, a novel drug delivery system with non-uniform drug distribution was developed and named 
NUDDMat (Non-Uniform Drug Distribution Matrix) (Cerea et al., 2018). The system consisted of overlaid 
layers having drug concentrations diminishing outwards according to a descending staircase function. 70 
Hypromellose was selected as the swellable hydrophilic polymer. The relevant amount in the best-proved 
configuration of the system was constant (30% w/w), while the percentage of an insoluble filler (DCP) 
increased from the innermost to the outermost layer to compensate for the decrease in drug concentration. 
No drug tracer was loaded in the external layer in order to possibly mitigate the burst release phase. The 
system was fabricated by powder layering of predetermined drug/polymer/filler mixtures onto inert starting 75 
cores. Because powder layering involves no organic solvents nor long drying operations, thus allowing 
typical issues connected with liquid-based layering processes to be avoided, it was particularly advantageous 
in shortening the processing time as compared with previously described gradient systems (Foppoli et al., 
2019, 2017). NUDDMat proved able to prolong the release and extend its linearity over a relatively long 
period of time. 80 
On the basis of these premises the aim of the present study was to investigate i) the possibility of broadening 
the design concept of the prolonged-release hydrophilic matrix system with non-uniform drug distribution 
(NUDDMat) to APIs having solubility in a wide range, and ii) the feasibility of powder layering technique in 
application of relevant powder mixtures showing different physico-technological properties. 
 85 
2. Materials 
Lansoprazole was used as a slightly soluble tracer (SST) (Adare Pharmaceuticals, Italy, water solubility <1 
mg/mL, true density 1.51 mg/mL), acetaminophen as a moderately soluble tracer (MST) (CFM, Italy water 
solubility 14.1 mg/mL, true density 1.13 g/mL) and losartan potassium as a highly soluble tracer (HST) 
(Adare Pharmaceuticals, Italy, freely soluble in water, true density 1.20 mg/mL) (Foglio Bonda et al., 2016; 90 
Maroni et al., 2013; Tabatar et al., 1992; Venkateswara Reddy et al., 2014). High viscosity hypromellose 
(HPMC, Methocel® K15M, Colorcon, Italy) (apparent viscosity, 2% in water at 20 °C 6138–9030 mPa·s, 
USP substitution type 2208, true density 1.32 g/mL, sieved <125 µm) was used as the hydrophilic swellable 
polymer (Colorcon, 2000; Qi et al., 2003; Wu et al., 2005). Dibasic calcium phosphate dihydrate (DCP, 
Emcompress® premium powder, JRS, Germany, true density 2.21 g/mL) was employed as a diluent (Roberts 95 
and Rowe, 1985). Fumed silica (Aerosil® 200, Evonik, Germany) was added as a glidant to the powder 
mixtures, and povidone (PVP, Kollidon® 30, BASF, Germany, true density 1.11 g/mL) was used as the 
binder in aqueous solution (Marsac et al., 2006). Microcrystalline cellulose (MCC) nonpareils having 
nominal diameter of 850 µm were employed as starting cores (Cellets® 700, Pharmatrans-Sanaq, 
Switzerland, true density 1.46 g/L) (Sun, 2005). Polysorbate 80 (TEGO SMO 80, A.C.E.F., Italy) was used 100 
for preventing aggregation of powders during particle size analysis. 
 
3. Methods 
3.1. Physico-techonological characterization of drug tracers 
Mean particle size and size distribution of tracers were measured by single particle optical sensing (SPOS) 105 
technique using Accusizer C770 (PSS Inc. Santa Barbara, USA) equipped with an autodiluting system 
(Autodiluter PAT, PSS Inc. Santa Barbara, CA, USA). HST, MST, SST and DCP powders were suspended 
in 1 mL of filtered saturated aqueous solution (0.22 µm nylon filter, Millipore) containing 0.5% (w/v) of 
polysorbate 80. HPMC was tested in absolute ethanol (≥ 99.5%). Analyses were performed in triplicate and 
size was expressed as the mean diameter and Span. 110 
𝑆𝑝𝑎𝑛 =  
𝑑10−𝑑90
𝑑50
   (1) 
Specific surface area was measured by means of SA3100 Surface Area Analyzer (Beckman  Coulter, UK) 
according to the BET method using N2 as adsorbate gas (USP 32 Physical Test. Specific Surface Area. 
Volumetric Method). Prior to analysis, the samples (approximately 2 g) were degassed at 90 °C under 
vacuum (0.4 Pa) for 1 h. The measurements were carried out in triplicate. 115 
Compressibility index was calculated according to Eur. Pharm. 10.0 by testing approximately 50 g of 
powders using a jolting volumeter (STAV 2003, J. Engelsmann A.,D; 1250 taps) with 100 mL volumetric 
cylinder. Values reported are the average of 3 determinations. Flowability properties were classified 
according to the Eur. Pharm 10.0 ranking (European Pharmacopoeia, 2019). 
 120 
3.2. Manufacturing of NUDDMat and UDDMat 
Powder blends to be layered or tableted were obtained by mixing in Turbula® (Willy A. Bachofen, 
Switzerland) at 24 rpm for 20 min. 
Powder layering was performed by a fluid bed apparatus (GPGC 1.1, Glatt, Germany) equipped with rotor 
insert. The operating conditions set up were as follows: nozzle port size 1.2 mm, inlet air temperature 30 °C, 125 
product temperature 26-28 °C, outlet air temperature 23 °C, air flow 70 m3/h, nebulization air pressure 2 bar, 
product pressure 1100 Pa, disk rotation speed 700 rpm, liquid binder feeding rate 12 g/min, powder feeding 
rate 20 g/min. For any layering step, 500 g of starting substrate, either inert seeds or intermediate layered 
units (1 to 4 layers), was loaded into the processing chamber. Powder addition was carried out via a forced 
powder feeder while spraying in a continuous mode a binding solution onto preheated substrate. The amount 130 
of powder formulations to be layered was established so as to reach the target 315 µm increase in thickness 
by assuming a 5% layer porosity and a 90% process yield. The diameter and weight of the coated units were 
regularly checked in-process by withdrawing samples (n=100) at prefixed time intervals. After each layering 
step, a drying phase was performed at the inlet air temperature of 60 °C for 30 min, and process yield was 
calculated as the percentage layered units/starting materials (seeds, layering powders, binder) weight ratio.  135 
The UDDMat (Uniform Drug Distribution Matrix) system containing MST was manufactured by tableting, 
using a rotary tablet press (mod. AM8S, Officine Meccaniche Ronchi, Italy) equipped with 4 mm diameter 
concave punches (4 mm curvature radius) at a 7 kN compression force (batch size 50 g). The nominal weight 
of the matrices was 45 mg. The composition of the powder blend employed was the same as in 5-layer 
NUDDMat MST, as reported in Table 1.  140 
 
3.3. Physico-technological characterization of layered and tableted matrices 
Layered units (n=100) and tablets (n=20) were checked for weight and for thickness and/or diameter by a 
precision caliper (CD 150, Mitutoyo, Italy). The aspect ratio was calculated dividing the maximum by the 
minimum diameter of each unit, as measured by digital microscope (Dino Lite Pro AM 413T, Italeco, Italy) 145 
(n=20). Friability was assessed according to Eur. Pharm. 10.0 by a friabilometer (mod. EF-2, Electrolab, 
Italy) rotating at 25 rpm for 4 min. 6.5 g of units was used for the measurements. The data obtained were 
expressed as loss-on-weight percentages. Crushing strength (n=10) was measured by the equipment reported 
in Eur. Pharm. 10.0 (mod. T3, Erweka, Germany). Porosity (E) of units, expressed as percentage, was 
calculated according to the equation: 150 
 
𝐸 (%) = [1 −
𝑉𝑡
𝑉𝑏
] ∙ 100  (2) 
 
where Vt is the average true volume and Vb is the mean bulk volume. 
Cross-section morphology was analyzed by a scanning electron microscope (SEM; FEI, Carl Zeiss, 155 
Germany). Samples were gold-sputtered using a plasma evaporator under vacuum, and photomicrographs 
were acquired at an accelerated voltage of 10 kV at differing magnifications. 
 
3.4. Release testing and data analysis of layered and tableted matrices  
Weighed samples approximately corresponding to an overall amount of 50 mg of tracer were tested for 160 
release by a Eur. Pharm. 10.0 dissolution apparatus (mod. 2100B, Distek Italia, Italy) equipped with rotating 
baskets using 900 mL of fluid thermostated at 37 ± 0.5 °C and stirred at 100 rpm. Purified water, 
hydrochloric acid solution pH 1.2 and phosphate buffer pH 4.5 or 6.8 were employed as the media. Release 
tests were performed in triplicate. Tracers were assayed by spectrophotometer (Lambda 25, Perkin Elmer 
Italia, Italy) at the wavelength of 250, 243 and 284 nm for losartan potassium, acetaminophen and 165 
lansoprazole, respectively, after verifying agreement with results acquired by HPLC validated methods 
(Cerea et al., 2018; Chambers et al., 2005; Del Curto et al., 2014; United States Pharmacopeia Convention, 
2017). 
For statistical comparison of release profiles, similarity factor f2 was applied. f2 ≥ 50 (50-100) indicated 
similarity (Administration Centre For Drug US Department of Health and Human Services Food and Drug 170 
and CDER Evaluation And Research, 1997).  
UDDMat release data were analyzed according to the equation: 
 
𝑀𝑡
𝑀∞
= 𝑘𝑡𝑛  (3) 
where Mt/M∞ is the drug fraction released at time t, n exponent indicates the mechanism/kinetics of release 175 
and k is a constant incorporating structural and geometrical characteristics of the matrix. Analysis of data 
was performed in the Mt/M∞ <0.60 curve portion, calculating confidence intervals (c.i.) at 95% (Colombo et 
al., 1985; Korsmeyer et al., 1983; Sinclair and Peppas, 1984). 
NUDDMat release data were also analyzed by Eq. (3), in the Mt/M∞<0.90 curve portion. In this case, n 
values were used in a merely descriptive way to highlight progressive shift of kinetics toward linearity. n = 1 180 
indicated apparent zero-order release. Values ˂ 0.5 and >1 could also be taken into account. 
The extent of linearity of release profiles was evaluated through the Durbin-Watson statistics, which enables 
to identify zero-order portions in each curve (Durbin and Watson, 1950; van der Voet et al., 1983) . 
 
4. Results and discussion 185 
For the purpose of evaluating the impact of APIs with different solubility on powder layering feasibility and 
the release performance of the resulting units, the matrix design was maintained as previously set up (Cerea 
et al., 2018), including: 
i) 5 layers having nominal thickness of 315 µm (starting core 850 µm nominal diameter); 
ii) decreasing concentration of the drug tracer from the innermost (1st) layer toward the outermost 190 
(5th) one; 
iii) constant concentration of hydrophilic swellable release-controlling polymer throughout all layers 
(30% w/w); 
iv) increasing concentration of an insoluble filler (DCP) from the 1st to the 5th layer; 
v) no drug tracer in the 5th layer in order to counteract the burst release. 195 
The concentration of drug tracer was decreased between contiguous layers from the inside toward the outside 
of the matrix reflecting a descending staircase function, thus tending to an apparent linear mode, from 65% 
in the 1st layer to 0% in the 5th one. Fig. 1 reports a schematic outline of the NUDDMat system, while Fig. 2 
presents the concentration profiles for the three main components, i.e. the tracer, polymer and filler. 
 200 
 
Fig. 1.  Schematic 3D representation of the NUDDMat system. Drug tracer concentration is indicated by color intensity. 
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Fig. 2. Theoretical concentration patterns for drug tracer, polymer and filler along the radius of the NUDDMat system.  
Relying on the above-presented design concept, the percentage compositions of the powder blends reported 215 
in Table 1 were used. 
 
Table 1 
Nominal composition of the different powder blends 
#PVP, added as a binder in aqueous solution, was present in the layer composition at 3%  220 
##composition equal to final NUDDMat (5 layers). PVP was added in powder form 
#, ## fumed silica was added at 0.75% on total powder weight 
 
Three small molecules having different aqueous solubility were selected: losartan potassium (HST), 
acetaminophen (MST) and lansoprazole (SST), used as highly soluble, moderately soluble and slightly 225 
soluble drug tracers, respectively. 
Because powder layering involves the use of relatively small-sized powders, generally not above 150 µm, in 
order to improve the packing of particles in layer formation, fine grade active pharmaceutical ingredients 
(APIs) and excipients were employed (Table 2). The particle dimensions of HST were relatively larger as 
compared with MST and SST, the latter exhibiting a relatively narrow range and the highest specific surface 230 
area. The relatively high surface area of HPMC in spite of the large particle size might be due to the great 
porosity with respect to other materials. The morphological particle characteristics of the APIs selected were 
well evident by SEM analysis, which pointed out agglomeration of SST powder (Fig. 3). The APIs were 
categorized according to the Eur. Pharm. 10.0 classification as “very very poor” flowable powders 
(European Pharmacopoeia, 2019). DCP and HPMC, also employed as fine powders, proved to only slightly 235 
enhance the flow properties of the resulting mixtures. 
 
  
 Layer Tracer (%) HPMC (%) DCP (%) 
NUDDMat# 
(Non-uniform Drug Distribution 
Matrices) 
1st 65 30 5 
2nd 50 30 20 
3rd 35 30 35 
4th 20 30 50 
5th - 30 70 
UDDMat## 
(Uniform Drug Distribution 
Matrices) 
- 17 30 53 
Table 2 
Physico-technological characteristics of drug tracers, polymer and filler 240 
Tracer Particle size Specific surface area Compressibility index 
HST 103.59 µm (42.07 Span) 0.326 m2/g (0.012 sd) 38.0% (4.8 sd) 
MST 47.02 µm (13.53 Span) 0.560 m2/g (0.016 sd) 42.5% (5.3 sd) 
SST 12.27 µm (1.16 Span) 2.105 m2/g (0.025 sd) 50.1% (7.1 sd) 
HMPC 75.55 µm (4.48 Span) 1.520 m2/g (0.035 sd) 31.1% (2.4 sd) 
DPC 13.2 µm (3.25 Span) 1.250 m2/g (0.045 sd) 25.2% (2.7 sd) 
 
a)    
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Fig. 3. SEM photomicrographs of HST (a), MST (b) and SST (c) powders.  
50 µm 
50 µm 
50 µm 
As a first step, it was necessary to define the nominal percentage composition of the NUDDMat systems. In 
this respect, preset tracer:HPMC weight ratios, as reported in Table 1, were relied on to calculate the formula 
of the layers, also accounting for the amounts of fumed silica (0.72%) and of PVP (3.00%). The percentage 270 
of PVP was derived from the fixed 5:3 weight ratio between layered powder and 5% w/w binding solution. 
The total mass of materials needed for each layer was calculated on the basis of the average true density of 
the formulation by assuming a layer porosity of 5% (Table 3). The values reported were subsequently used to 
establish the amounts of powder and binding solution to be loaded to reach the desired thickness for each 
layer. 275 
 
Table 3  
Nominal diameter, volume, weight, drug load and drug concentration, for each layer and cumulative, in NUDDMat 
systems containing different drug tracers. 
 280 
  
core 
seed 
1-layer 2-layer 3-layer 4-layer 5-layer/2 5-layer 
Cumulative diameter (mm) HST/MST/SST 0.85 1.48 2.11 2.74 3.37 3.69 4.00 
Layer volume (mm3) HST/MST/SST - 1.38 3.22 5.85 9.26 6.16 13.46 
Cumulative volume (mm3) HST/MST/SST 0.32 1.70 4.92 10.77 20.03 26.19 33.49 
Layer weight 
(mg) 
HST - 1.64 4.28 8.58 14.87 11.02 24.10 
MST - 1.58 4.17 8.45 14.75 11.02 24.10 
SST - 1.89 4.73 9.16 15.40 11.02 24.10 
Cumulative weight 
(mg) 
HST 0.50 2.13 6.41 14.99 29.86 40.88 53.96 
MST 0.50 2.08 6.25 14.70 29.45 40.47 53.55 
SST 0.50 2.39 7.12 16.28 31.67 42.69 55.77 
Layer drug load 
(mg) 
HST - 1.02 2.06 2.89 2.86 0.00 0.00 
MST - 0.99 2.01 2.85 2.84 0.00 0.00 
SST - 1.18 2.28 3.09 2.96 0.00 0.00 
Cumulative drug load 
(mg) 
HST - 1.02 3.08 5.97 8.84 8.84 8.84 
MST - 0.99 3.00 5.84 8.68 8.68 8.68 
SST - 1.18 3.46 6.55 9.51 9.51 9.51 
Layer drug concentration 
(mg/mm3) 
HST - 0.60 0.42 0.27 0.14 0.00 0.00 
MST - 0.72 0.62 0.49 0.31 0.00 0.00 
SST - 0.86 0.71 0.53 0.32 0.00 0.00 
The 315 µm-thick layers included in the system design involved 5 sequential processing steps. For each one, 
the starting batch size was of 500 g, of either inert seeds or intermediate layered units. The quantity of 
powder required for the single layers was calculated based on the values reported in Table 3 and the 
assumption of a 90% process yield, previously assessed by averaging the results from preliminary trials. The 285 
binding solution having the established PVP concentration was proved to enable proper adhesion of particles 
onto the substrate regardless of remarkable differences in the solubility of the drug tracers selected. The 
operating parameters set turned out to be suited for all powder formulations to be layered. Particularly, the 
5:3 weight ratio between powder feeding rate (20 g/min) and liquid binder spraying rate (12 g/min) was 
maintained during the whole process with the 3 tracers investigated. 290 
A drying phase was carried out when the loading of the whole amount of powder was accomplished. The 
resulting units, both intermediate and final, exhibited size and weight uniformity, satisfactory aspect ratio, 
relatively low porosity and negligible friability (Table 4a). Pictures of the uncoated seeds and of systems 
with increasing layers containing the different tracers are reported in Fig. 4, and SEM photomicrographs are 
shown in Fig. 5. 295 
The increases in weight and diameter were close to the expected values, although slightly higher data were 
obtained because the process yield was in all cases found greater than the assumed 90%.  
 
 
Fig. 4. Units ranging from core seed to final NUDDMat system containing HST (scale in millimeters). 300 
 
  
seed 1-layer 2-layer 3-layer 4-layer 5-layer 
 
a)  
b)  
c)  305 
Fig. 5. SEM photomicrographs of cross-sectioned NUDDMat systems containing HST (a), MST (b) e SST (c).  
500 µm 
500 µm 
500 µm 
Table 4 
Physico-technological characteristics of NUDDMat systems. 
a) 
 310 
b) 
 
 
In the SEM images of cross-sectioned units, the internal structure appeared different depending on the 
concerned API. In no case, an onion-like aspect, which might have resulted from successive application of 315 
the diverse formulations, could clearly be seen. 
The release profiles of units provided with 1 to 5 layers are reported in Fig. 6. With increasing number of 
layers applied, the release was progressively slowed down. A lower release rate was observed according to 
the solubility of the drug tracer. 
HST- (NUDDMat HST) and MST-containing (NUDDMat MST) systems displayed analogous release 320 
profiles both for intermediate units having 1 to 4 layers and for final systems. In the units provided with 1 
layer only, with all tracers considered, an effective matrix structure could not be formed due to the very 
limited amount of polymer, and an early breakup occurred. 
SST-containing units with 1 to 4 layers showed sigmoidal release profiles. This may be due to the relatively 
low dissolution rate of such a drug tracer, which would ultimately be preceded by formation of a swollen 325 
HPMC barrier effective in hindering release. 
The application of the outer layer, devoid of tracer, always led to an initial slower release phase, which was 
especially evident in the case of the system containing SST (NUDDMat SST), with a duration of 4-5 h. In 
the latter case, because of the poor API solubility, erosion may have indeed prevailed over diffusion as the 
release-controlling mechanism (Lee, 1986). This seemed to be supported by the increase in the variability of 330 
release data that was observed for NUDDMat SST systems with 5 layers. The system containing SST 
yielded an apparent zero-order release in the absence of the 5th layer (NUDDMat SST 4-layer). In this 
NUDDMat 
unit 
Weight 
(mg ± s.d.) 
Diameter 
(mm ± s.d.) 
Porosity 
(%) 
Aspect ratio 
(value ± s.d.) 
Crushing 
strength 
(N ± s.d.) 
Friability 
(%) 
HST 55.01±1.28 4.09±0.08 6.25 1.11±0.03 125±12 0.11 
MST 54.05 ±1.79 4.11±0.08 7.35 1.09±0.02 146±8 0.13 
SST 56.05±1.59 4.03±0.08 8.21 1.15±0.04 101±6 0.21 
NUDDMat 
unit 
Weight 
(mg ± s.d.) 
Diameter 
(mm ± s.d.) 
Porosity 
(%) 
Aspect ratio 
(value ± s.d.) 
Crushing 
strength 
(N ± s.d.) 
Friability 
(%) 
HST/2 42.02±1.08 3.71±0.04 5.89 1.10±0.03 101±10 0.15 
MST/2 41.45±1.25 3.68±0.06 7.51 1.02±0.03 110±10 0.13 
SST/2 42.58±1.56 3.71±0.04 8.50 1.01±0.02 90±6 0.18 
respect, modulation of the concentration gradient and/or modification of the layer configuration as a function 
of drug solubility could represent a viable strategy to pursue zero-order release. 
Data were analyzed by exponential Eq. (3), here applied for descriptive purposes only, confirming the above 335 
considerations. In particular, an increase in n values for NUDDMat HST and NUDDMat MST indicated 
progressive shifting of the profiles towards zero-order kinetics, while n largely >1 relevant to NUDDMat 
SST was associated with deferred release (Table 5). With NUDDMat HST and NUDDMat MST systems (5-
layer units), n slightly >1 was found, pointing out initially lowered rate of release and consequent tendency 
to sigmoidal curves. In order to address such an issue, the thickness of the outer layer with no tracer was 340 
halved to give NUDDMat HST/2, NUDDMat MST/2 and NUDDMat SST/2 (Table 4b). Porosity, aspect 
ratio and mechanical resistance were not altered with respect to the original NUDDMat systems, while the 
release performance was changed as shown in Fig. 7.  
As pursued, through reduction of the thickness of the 5th layer to 157.5 µm, it was possible to attain linear 
release of HST and MST. Indeed, the resulting n values were close to unity. Moreover, through the Durbin-345 
Watson statistics, linearly released fractions in the range 0.20 to 0.88, between 1 and 5 h, were calculated 
from NUDDMat HST/2, while with NUDDMat MST/2 release was found linear from 0.17 to 0.87 fractions, 
between 1 and 6 h. On the other hand, in the case of NUDDMat SST/2 this strategy proved only useful to 
shorten the starting lag phase, and the release pattern still appeared sigmoidal as testified by the 
corresponding n value. 350 
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Fig. 6. Release profiles from NUDDMat systems containing HST (a), MST (b) and SST (c). 
 385 
 
 
Fig. 7. Release profiles from NUDDMat systems with 5th layer having 157.5 µm thickness. 
 
  390 
Table 5. 
Release parameters according to exponential Eq. (3). 
 n confidence limit 95% k R2 
NUDDMat HST 1-layer * * * * 
NUDDMat HST 2-layer 0.685 0.001 0.886 1.000 
NUDDMat HST 3-layer 0.750 0.001 0.575 1.000 
NUDDMat HST 4-layer 0.761 0.001 0.354 1.000 
NUDDMat HST/2 1.069 0.035 0.170 0.993 
NUDDMat HST 1.086 0.001 0.060 0.992 
NUDDMat MST 1-layer * * * * 
NUDDMat MST 2-layer 0.640 0.002 0.676 1.000 
NUDDMat MST 3-layer 0.686 0.003 0.480 1.000 
NUDDMat MST 4-layer 0.697 0.001 0.345 0.999 
NUDDMat MST/2 0.982 0.002 0.168 1.000 
NUDDMat MST 1.154 0.002 0.081 0.999 
NUDDMat SST 1-layer * * * * 
NUDDMat SST 2-layer 1.374 0.002 0.209 0.999 
NUDDMat SST 3-layer 1.531 0.001 0.096 0.999 
NUDDMat SST 4-layer 1.510 0.002 0.060 0.999 
NUDDMat SST/2 1.874 0.003 0.020 0.993 
NUDDMat SST 1.637 0.003 0.009 0.945 
NUDDMat MST pH 1.2 1.042 0.074 0.100 0.997 
NUDDMat MST pH 4.5 1.197 0.146 0.077 0.997 
NUDDMat MST pH 6.8 1.092 0.146 0.075 0.945 
UDDMat MST pH 1.2 0.768 0.037 0.233 0.999 
UDDMat MST pH 4.5 0.661 0.110 0.264 0.999 
UDDMat MST pH 6.8 0.615 0.182 0.269 0.998 
* not applicable due to rapid erosion/disintegration 
A well-known advantageous feature of HPMC-based matrices, provided that the API has pH-independent 
solubility, is consistent performance regardless of diverse pH of the environment as encountered in the 395 
gastrointestinal tract. In order to verify whether such a behavior would also apply to the proposed gradient 
matrix system, release was evaluated in compendial fluids having different pH values. Particularly, this study 
was conducted using NUDDMat MST, the dissolution properties of acetaminophen being unaffected by pH. 
Tableted matrices with the same quali-quantitative composition of final NUDDMat MST (tracer, polymer, 
diluent, binder), yet with uniform drug distribution (UDDMat MST), were also prepared for comparison. 400 
With both the uniform and non-uniform drug distribution systems, no influence of the fluid pH was observed 
on the release performance, as indicated by similarity factors f2 always > 80 within the two data sets (Fig. 8). 
Moreover, a clear tendency toward zero-order of NUDDMat MST release profiles was highlighted in all 
fluids. Notably, in the case of UDDMat systems, n values hold mechanistic meaning in exponential Eq. (3), 
thus pointing out the expected anomalous non-fickian nature of release. 405 
  
  
Fig. 8. Release profiles from NUDDMat MST and UDDMat MST systems in pH 1.2, 4.5 and 6.8 fluids. 
 410 
5. Conclusions 
According to a formulation design previously demonstrated successful, the NUDDMat hydrophilic matrix 
system, intended for zero-order release, was manufactured by subsequent deposition onto inert cores of 
layers having outwards decreasing concentrations, according a staircase profile, of drug tracers having high, 
medium and low water solubility. Powder layering technique was used, and different mixtures were 415 
employed wherein the drug and the release-controlling polymer had percentage compositions set for each of 
the overlaid layers. The systems showed good physico-technological properties, and the control on the rate 
of release, irrespective of the solubility characteristics of the tracers, turned out more effective by increasing 
the number of layers applied. NUDDMat systems provided with 5 layers having 315 µm thickness and 
without drug in the external layer generated in all cases sigmoidal release profiles with an initial low-rate 420 
phase. However, by halving the thickness of the 5th layer, linear release of HST and MST was achieved. The 
lag time had a duration of approximately 4 h in the NUDDMat SST profile, and only a reduction thereof 
could be obtained when a halved outer layer was applied. Higher variability of data would in principle 
support a mainly erosive mechanism of release in the case of systems loaded with the poorly soluble tracer. 
The pH-independent release behavior of NUDDMat was assessed by testing the MST-containing system as 425 
compared with tableted uniform drug distribution system having the same quali-quantitative composition. In 
particular, similar release profiles were obtained using media having pH 1.2, 4.5 and 6.8. 
Based on the results obtained, the proposed NUDDMat hydrophilic matrix gradient system was confirmed to 
be an advantageous delivery platform able to provide zero-order release of drug molecules having different 
solubility. Further formulation studies, mainly leveraging modulation of the concentration gradient within the 430 
matrix and of the thickness of the various layers, need to be faced to broaden the scope of application of 
NUDDMat technology to poorly water soluble drugs. 
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Fig. 1. Schematic 3D representation of the NUDDMat system. Drug tracer concentration is indicated 
by color intensity. 590 
 
Fig. 2. Theoretical concentration patterns for drug tracer, polymer and filler along the radius of the 
NUDDMat systems. 
 
Fig. 3.  SEM photomicrographs of HST (a), MST (b) and SST (c) powders. 595 
 
Fig. 4.  Units ranging from core seed to final NUDDMat system containing HST (scale in millimeters). 
 
Fig. 5. SEM photomicrographs of cross-sectioned NUDDMat systems containing HST (a), MST (b) e 
SST (c). 600 
 
Fig. 6. Release profiles from NUDDMat systems containing HST (a), MST (b) and  SST (c). 
 
Fig. 7. Release profiles from NUDDMat systems with 5th layer having 157.5 µm thickness. 
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Fig. 8. Release profiles from NUDDMat MST and UDDMat MST systems in pH 1.2, 4.5 and 6.8 
fluids. 
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